Wednesday, 14 September 2016

Risk Factors Associated with Clostridium difficile Infection in A Pediatric Hematology-Oncology Ward

Clostridium difficile is An anaerobic spore forming gram positive bacilli. It is transmitted through fecal-oral route and can cause Clostridium difficile infection (CDI) when there is alteration in normal bowel flora mostly secondary to antibiotic use. Infections with Clostridium difficile ranges from asymptomatic carrier or mild diarrhea to pseudomembranous Colitis. It is the most common cause of health-care associated diarrhea

Clostridium difficile Infection
The incidence of CDI is increasing worldwide especially after the emergence of North American pulsed-field gel electrophoresis type 1 (NAP-1) strain which wasidentified in 2002 and was the cause of multiple outbreaks of CDI. NAP-1 strain is known to produce greater quantities of Toxin A & B with higher risk of relapse resulting in more series diseases. Regarding the incidence of CDI in Saudi Arabia, There is only one small study in 2010 describing the annual prevalence which is around 1 per 1000 discharge. But there is no published data on CDI in pediatric hematology-oncology population.CDI prevalence in pediatrics population is low, but currently it is recognized as an increasingly important pathogen in children. There is increasing incidence of CDI among pediatric patients with estimated annual incidence rate of 2.6-4/1000 admission in published reports CDI accounted for 32% of diarrheal episodes among hospitalized pediatric patients.








No comments:

Post a Comment